QCI Asset Management’s GSK GSK Stock Holding History

QCI Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-172	Closed	-$9K	–	607
2019 Q2	$9K	Buy	+172	New	+$8.63K	﹤0.01%	463
2017 Q3	–	Sell	-141	Closed	-$8K	–	573
2017 Q2	$8K	Buy	+141	New	+$7.52K	﹤0.01%	455
2016 Q4	–	Sell	-13	Closed	-$1K	–	532
2016 Q3	$1K	Hold	13	–	–	﹤0.01%	502
2016 Q2	$1K	Hold	13	–	–	﹤0.01%	522
2016 Q1	$1K	Hold	13	–	–	﹤0.01%	501
2015 Q4	$1K	Hold	13	–	–	﹤0.01%	501
2015 Q3	$1K	Hold	13	–	–	﹤0.01%	505
2015 Q2	$1K	Hold	13	–	–	﹤0.01%	481
2015 Q1	$1K	Hold	13	–	–	﹤0.01%	485
2014 Q4	$1K	Hold	13	–	–	﹤0.01%	509
2014 Q3	$1K	Hold	13	–	–	﹤0.01%	514
2014 Q2	$1K	Hold	13	–	–	﹤0.01%	496
2014 Q1	$1K	Hold	13	–	–	﹤0.01%	496
2013 Q4	$1K	Hold	13	–	–	﹤0.01%	509
2013 Q3	$1K	Sell	13 -1,280	-99%	-$82.4K	﹤0.01%	475
2013 Q2	$81K	Buy	+1,293	New	+$82.1K	0.02%	140

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

QCI Asset Management's GSK Position: Q3 2019 in Review

QCI Asset Management sold out of GSK (GSK) in Q3 2019, closing a stake of 172 shares — an estimated $9K sold.

QCI Asset Management first reported a position in GSK in Q2 2013 and held it in 16 quarters. The position peaked at $81K in Q2 2013. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

QCI Asset Management reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
QCI Asset Management sold 172 GSK shares in Q3 2019, an estimated $9K.
QCI Asset Management first reported a position in GSK in Q2 2013 and held it in 16 quarters.
QCI Asset Management's GSK position peaked at $81K in Q2 2013.
805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on QCI Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.